Nouscom Company Contacts

Nouscom

http://www.nouscom.com
Nouscom is a private clinical stage immuno-oncology company developing off-the-shelf and personalized cancer immunotherapies using proprietary viral vectors with demonstrated high immunogenicity in patients. Nouscom’s clinical pipeline includes NOUS-209, an off-the-shelf cancer immunotherapy assessing the efficacy of the treatment in... Read More
Contacts

Country

Switzerland

City

BS

Headquarters

BS, Basel-City

Profile

Industry

Biotechnology Research

Size

11 - 50

Funding

Total Rounds

4

Last Round

Wed Mar 20 2024

Last Round Series

Series C

Last Round Raised

$ 7,603,472